DeLyons Ron
SEC CIK 1811257 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CHE | CHEMED CORP | Dir | 2,052 | — | — | 5 | 2022-05-16 | 2026-05-18 |
Most active insiders at CHE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MCNAMARA KEVIN J | Pres, CEO, Dir | — | $7.63M |
| 2 | LINDELL ANDREA R | Dir | — | $602.6K |
| 3 | LEE SPENCER S | EVP | — | $541.0K |
| 4 | WALSH GEORGE J III | Dir | — | $218.9K |
| 5 | GRACE PATRICK P | Dir | — | $126.6K |
| 6 | Wherley Joel L | CEO - Vitas Healthcare | — | — |
| 7 | McCarthy Eileen P | Dir | — | — |
| 8 | Mount John Meredith Jr. | Dir | — | — |
| 9 | Judkins Brian C | VP, CLO | — | — |
| 10 | Heaney Christopher J | Dir | — | — |
| 11 | DeLyons Ron | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-19 09:17 | 2026-05-18 | CHE | CHEMED CORP | DeLyons Ron | Dir | A - Grant | $440.77 | +386 | 2,052 | +23% | +$170.1K | |
| 2025-05-20 | 2025-05-19 | CHE | CHEMED CORP | DeLyons Ron | Dir | A - Grant | $579.04 | +277 | 1,666 | +20% | +$160.4K | |
| 2024-05-21 | 2024-05-20 | CHE | CHEMED CORP | DeLyons Ron | Dir | A - Grant | $564.34 | +284 | 1,389 | +26% | +$160.3K | |
| 2023-05-16 | 2023-05-15 | CHE | CHEMED CORP | DeLyons Ron | Dir | A - Grant | $545.69 | +294 | 1,105 | +36% | +$160.4K | |
| 2022-05-17 | 2022-05-16 | CHE | CHEMED CORP | DeLyons Ron | Dir | A - Grant | $496.25 | +262 | 811 | +48% | +$130.0K |
Purchase Sale Sale after option exercise All abbreviations